Literature DB >> 3170722

Increasing intrathecal lymphocytosis and immunoglobulin G production in neurologically asymptomatic HIV-1 infection.

M A Andersson1, T B Bergström, C Blomstrand, S H Hermodsson, C Håkansson, G B Löwhagen.   

Abstract

Cerebrospinal fluid from 34 human immunodeficiency virus (HIV-1) seropositive patients, only four of whom had HIV-related neurological symptoms, was examined by cytology, protein quantification, isoelectric focusing and specific serological tests. CSF lymphocytosis and evidence of intrathecal IgG production, found in 21 and 20 respectively of the 34 patients, correlated significantly with the duration of the infection. Increasing IgG index was found in two patients with repeated CSF examinations during greater than 7 years. Intrathecal HIV antibodies were detected on Western blot in 32/34 patients. HIV antigen test positive in 5/34 sera was negative in all 34 CSF samples. Intrathecal B cell activation seems to increase during the early HIV infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170722     DOI: 10.1016/0165-5728(88)90010-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  White matter lesions in a young HIV-positive immunocompetent patient without cerebrovascular risk factors due to an ICA-thrombus.

Authors:  George Trendelenburg; Juri Katchanov; Florian Masuhr; Randof Klingebiel; Rolf Zschenderlein
Journal:  J Neurol       Date:  2005-07-18       Impact factor: 4.849

2.  Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.

Authors:  Sergio M de Almeida; Indianara Rotta; Clea E Ribeiro; Michelli F Oliveira; Antoine Chaillon; Ana Paula de Pereira; Ana Paula Cunha; Marise Zonta; Joao França Bents; Sonia M Raboni; Davey Smith; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2017-02-28       Impact factor: 2.643

3.  Radiological study of the brain at various stages of human immunodeficiency virus infection: early development of brain atrophy.

Authors:  R Raininko; I Elovaara; A Virta; L Valanne; M Haltia; S L Valle
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

4.  Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis.

Authors:  Sergio Monteiro de Almeida; Archana Bhatt; Patricia K Riggs; Janis Durelle; Deborah Lazzaretto; Jennifer Marquie-Beck; Allen McCutchan; Scott Letendre; Ronald Ellis
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

5.  Neuropathology of HIV infection in haemophiliacs: comparative necropsy study.

Authors:  M M Esiri; F Scaravilli; P R Millard; J N Harcourt-Webster
Journal:  BMJ       Date:  1989-11-25

Review 6.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11

7.  Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide.

Authors:  Hongwei Wang; Jinglin Sun; Harris Goldstein
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

8.  IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments.

Authors:  Sergio M De Almeida; Indianara Rotta; Bin Tang; Florin Vaida; Scott Letendre; Ronald J Ellis
Journal:  J Neuroimmunol       Date:  2021-03-08       Impact factor: 3.221

Review 9.  Herpesviruses--a rationale for antiviral treatment in multiple sclerosis.

Authors:  T Bergström
Journal:  Antiviral Res       Date:  1999-02       Impact factor: 5.970

Review 10.  Compartmentalized intrathecal immunoglobulin synthesis during HIV infection - a model of chronic CNS inflammation?

Authors:  Mickael Bonnan; Bruno Barroso; Stéphanie Demasles; Elsa Krim; Raluca Marasescu; Marie Miquel
Journal:  J Neuroimmunol       Date:  2015-05-16       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.